SEC Form 4 · accession 0001209191-17-047016
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert James Wills
Director
Period of report
Aug 1, 2017
Accepted (ET)
Aug 2, 2017 · 8:21 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 1, 2017 | P | 200 | $6.829 | A | 25,200 | D | |
| Common Stock | Aug 1, 2017 | P | 300 | $6.838 | A | 25,500 | D | |
| Common Stock | Aug 1, 2017 | P | 1,000 | $6.839 | A | 26,500 | D | |
| Common Stock | Aug 1, 2017 | P | 3,500 | $6.847 | A | 30,000 | D |
Table II — derivative securities
No Table II lines on this filing.